Search - Université de Rennes Access content directly

Filter your results

12 Results
authFullName_s : B. Fromenty
Image document

Molecular networking for drug toxicities studies: The case of hydroxychloroquine in covid-19 patients

P.-J. Ferron , B. Le Daré , J. Bronsard , C. Steichen , E. Babina et al.
International Journal of Molecular Sciences, 2022, 23 (1), pp.82. ⟨10.3390/ijms23010082⟩
Journal articles hal-03515202v1
Image document

Maternal and neonatal outcomes and prognostic factors in acute fatty liver of pregnancy

Y. Joueidi , K. Peoc'H , Maela Le Lous , Guillaume Bouzille , Chloé Rousseau et al.
European Journal of Obstetrics & Gynecology and Reproductive Biology, 2020, 252, pp.198-205. ⟨10.1016/j.ejogrb.2020.06.052⟩
Journal articles hal-02931946v1

Mitochondrial Dysfunction in Drug-Induced Liver Injury

A. Borgne-Sanchez , B. Fromenty
Mitochondrial Dysfunction in Drug-Induced Liver Injury, 1-2, wiley, pp.47-72, 2018, 9781119329725; 9781119329701. ⟨10.1002/9781119329725.ch5⟩
Book sections hal-01875340v1

Drug-induced mitochondrial toxicity

J. Massart , A. Borgne-Sanchez , B. Fromenty
Drug-induced mitochondrial toxicity, Springer International Publishing, pp.269-295, 2018, 9783319733449; 9783319733432. ⟨10.1007/978-3-319-73344-9_13⟩
Book sections hal-01809329v1

Hepatotoxicity in NAFLD: acetaminophen and other xenobiotics

B. Fromenty
Toxicology Letters, 2021, 350, pp.S56-S57. ⟨10.1016/s0378-4274(21)00383-0⟩
Journal articles hal-03467095v1

Drug-induced liver injury in obesity and nonalcoholic fatty liver disease

J. Allard , D. Le Guillou , K. Begriche , B. Fromenty
Advances in Pharmacology, Academic Press Inc., pp.75-107, 2019, ⟨10.1016/bs.apha.2019.01.003⟩
Book sections hal-02051781v1

Toxicité hépatique des inhibiteurs multikinases

M. Danielou , C. Houron , O. Mir , B. Fromenty , G. Perlemuter et al.
Hépato-Gastro & Oncologie Digestive, 2021, 28 (6), pp.695-704. ⟨10.1684/hpg.2021.2194⟩
Journal articles hal-03420611v1
Image document

Inhibition of mitochondrial fatty acid oxidation in drug-induced hepatic steatosis

B. Fromenty
Liver Research, 2019, 3 (3-4), pp.157-169. ⟨10.1016/j.livres.2019.06.001⟩
Journal articles hal-02443758v1
Image document

Xenobiotic-Induced Aggravation of Metabolic-Associated Fatty Liver Disease

J. Massart , K. Begriche , A. Corlu , B. Fromenty
International Journal of Molecular Sciences, 2022, 23 (3), pp.1062. ⟨10.3390/ijms23031062⟩
Journal articles hal-03557349v1

In vitro assessment of mitochondrial toxicity to predict drug-induced liver injury

M. Porceddu , N. Buron , P. Rustin , B. Fromenty , A. Borgne-Sanchez et al.
In vitro assessment of mitochondrial toxicity to predict drug-induced liver injury, 9781493976768, Humana Press Inc., pp.283-300, 2018, Methods in Pharmacology and Toxicology, 978-1-4939-7677-5; 978-1-4939-7676-8. ⟨10.1007/978-1-4939-7677-5_14⟩
Book sections hal-01777715v1

Mitochondrial dysfunction induced by xenobiotics Involvement in steatosis and steatohepatitis

K. Begriche , J. Massart , B. Fromenty
Mitochondria in Obesity and Type 2 Diabetes - Comprehensive Review on Mitochondrial Functioning and Involvement in Metabolic Diseases, Elsevier, pp.347-364, 2019, 9780128117521; 9780128118597. ⟨10.1016/B978-0-12-811752-1.00015-8⟩
Book sections hal-02569993v1

Importance of non-mitochondrial pathways in drug-induced hepatic steatosis: investigations with 12 steatotic drugs in HepaRG cells

J. Allard , S. Bucher , P. -J. Ferron , K. Begriche , P. Loyer et al.
Toxicology Letters, 2019, 314, pp.S60-S60
Journal articles hal-02310684v1